JDRF has awarded Dr. James Johnson and his team from the University of British Columbia (UBC) a grant of US$150,000 for a one-year study on whether insulin levels produced by transplanted pancreatic beta cells can be controlled and stabilized.
JDRF and Lilly Canada fund UHN research on new stem cell therapies aimed at eliminating the need for insulin injections.
Marley Greenberg from Thornhill, Ontario, will serve as the Canadian delegate at JDRF’s (Juvenile Diabetes Research Foundation) 2017 Children’s Congress, taking place from July 24 to 26 in Washington, D.C.
In June, over 40,000 Canadians across the country will rally together at the 2017 JDRF TELUS Walk to Cure Diabetes, to raise awareness and funds and help change the face of type 1 diabetes (T1D) forever.
JDRF and Lilly Canada requesting applications from postdoctoral fellows engaged in clinical type 1 diabetes research
JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce that Eli Lilly Canada Inc. (Lilly Canada) has provided $120,000 in support of two CCTN postdoctoral fellows for one year in the sum of $60,000 each.
Canadian business executive, Tom Gaglardi, President of Northland Properties Corporation and owner of the Dallas Stars, presented a generous $3M gift to JDRF Canada to support type 1 diabetes research in the areas of encapsulation, and beta cell replacement and regeneration.
Building a strong partnership to accelerate type 1 diabetes clinical trials research
JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow from the University of British Columbia (UBC).
$550,000 raised to accelerate funding for type 1 diabetes research
JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
TORONTO – October 20, 2016, JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia – a common, potentially life-threatening, risk for people living with type 1 diabetes ...